Rare Musculoskeletal Disorder Treatments Market is on the verge of a transformative decade, expected to grow from USD 3.8 billion in 2025 to USD 8.9 billion by 2035, registering a robust CAGR of 8.9%, according to the latest industry projections. The upcoming decade will redefine therapeutic approaches for rare diseases through advanced gene therapy platforms, precision...